← Back to Clinical Trials
Recruiting NCT07520396

NCT07520396 Combined Effects of Swiss Ball Exercises and Diaphragmatic Breathing in Pregnant Females

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07520396
Status Recruiting
Phase
Sponsor Riphah International University
Condition Urinary Incontinence
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2025-08-31
Primary Completion 2026-09-30

Eligibility & Interventions

Sex Female only
Min Age 20 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
kegels exercisesDiaphragmatic breathing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2025-08-31 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

30 to 60 percent of the pregnant females experience stress urinary incontinence depending on various factors like trimester, parity and body weight. Stress urinary incontinence is a common yet often underreported condition affecting pregnant women, characterized by involuntary leakage of urine during physical activities such as coughing, sneezing, or exercising. Stress urinary incontinence majorly occurs due to increased intra-abdominal pressure and weakened pelvic floor muscles which are further strained during pregnancy. Despite its impact on quality of life, awareness and management remains inadequate. Strengthening the pelvic floor muscles plays a critical role in managing stress urinary incontinence and Swiss ball exercises have emerged as an effective and low impact method to improve core stability and pelvic floor muscle strength. These exercises engage deep abdominal and pelvic muscles in a functional and dynamic way, potentially enhancing both physical and psychological well-being during pregnancy. . The study will be conducted as a randomized control trial involving females with stress urinary incontinence in Zia Hospital Lahore and Ittefaq Hospital Lahore. The study will be completed within 10 months of synopsis approval. A non-probability sampling technique will be employed and 42 patients will be enrolled after randomization. Participants will be divided into two groups. Group A will undergo a structured program involving Swiss ball exercises combined with diaphragmatic breathing. Group B will receive Swiss ball exercises without diaphragmatic breathing. Kegel exercises will be considered the baseline treatment. Outcome measures will include syptoms of stress urinary incontinence (using International Consultation Incontinence Questionnaire), pelvic floor muscle strength (assessed through standardized tools i.e. Modified Oxford Scale) and self-reported quality of life (using validated questionnaires i.e. King's Health Questionnaire). The data collected will be analyzed using IBM SPSS statistics version 25.

Eligibility Criteria

Inclusion Criteria: * • Females with singleton pregnancy * Females with urinary incontinence * Age range between 20-40 * Females with diagnosed with mild to moderate stress urinary incontinence * Females with weak pelvic floor muscles Exclusion Criteria: * • Females who are not pregnant * Females who have had any previous history of hysterectomy * Females with placenta previa * Females with UTI * Females with preterm labor * Females with pelvic organ prolapse

Contact & Investigator

Central Contact

imran amjad, phd

✉ imran.amjad@riphah.edu.pk

📞 03324390125

Principal Investigator

Masooma Saleem, MSPT WH

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07520396 clinical trial?

This trial is open to female participants only, aged 20 Years or older, up to 40 Years, studying Urinary Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07520396 currently recruiting?

Yes, NCT07520396 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07520396 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07520396 clinical trial?

NCT07520396 is sponsored by Riphah International University. The principal investigator is Masooma Saleem, MSPT WH at Riphah International University. The trial plans to enroll 42 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology